These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1438409)

  • 41. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
    Miller G; Brashear T; Stone M; Fay J
    Int J Cell Cloning; 1991 Sep; 9(5):503-10. PubMed ID: 1955738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J; Fehér I
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation.
    Lee C; Brouillette M; Lamb L; Pati A; Brown S; Thompson J; Parrish R; Henslee-Downey PJ; Gee AP
    Prog Clin Biol Res; 1994; 389():523-32. PubMed ID: 7700917
    [No Abstract]   [Full Text] [Related]  

  • 44. A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody.
    Rhodes EG; Baker PK; Duguid JK; Davies JM; Cawley JC
    Bone Marrow Transplant; 1992 Dec; 10(6):485-9. PubMed ID: 1490198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
    Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy.
    Aihara M; Aihara Y; Schmidt-Wolf G; Schmidt-Wolf I; Sikic BI; Blume KG; Chao NJ
    Blood; 1991 May; 77(9):2079-84. PubMed ID: 1673356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autologous bone marrow transplantation for acute leukemia using ferromagnetic microparticles and monoclonal antibody-purged marrows: demonstration of effectiveness by polymerase chain reaction.
    Bieva C; Martiat P; Ferster A; Sariban E; Kedar A; Erdos G; Bron D; Debusscher L; Stryckmans P
    Prog Clin Biol Res; 1992; 377():197-204. PubMed ID: 1438416
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
    Kramer B; Makrynikola V; Bradstock K
    Prog Clin Biol Res; 1992; 377():41-7. PubMed ID: 1438438
    [No Abstract]   [Full Text] [Related]  

  • 49. [In vitro manipulation of bone marrow cells for bone marrow transplantation].
    Morishima Y
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3034-43. PubMed ID: 3056275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD48 monoclonal antibody K31 for bone marrow transplantation.
    Dreger P; Steinmann J; Schmitz N; Eckstein V; Löffler H; Müller-Ruchholtz W
    Prog Clin Biol Res; 1992; 377():441-7. PubMed ID: 1438442
    [No Abstract]   [Full Text] [Related]  

  • 51. Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation.
    Ciobanu N; Paietta E; Andreeff M; Papenhausen P; Wiernik PH
    Exp Hematol; 1986 Aug; 14(7):626-35. PubMed ID: 3525202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
    Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
    Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
    Cobbold SP; Hale G; Clark MR; Waldmann H
    Prog Clin Biol Res; 1990; 333():139-51; discussion 152-4. PubMed ID: 2308978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
    Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP
    IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ex-vivo treatment of a bone marrow graft].
    Bieva CJ
    Rev Med Brux; 1992 May; 13(5):177-82. PubMed ID: 1609193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M; Mary JY; Sainteny F
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination chemotherapy and verapamil to purge drug resistant leukemia cells from human bone marrow.
    Cairo MS; Toy C; Sender L; Bennetts G; van de Ven C
    Prog Clin Biol Res; 1990; 333():47-55. PubMed ID: 2308995
    [No Abstract]   [Full Text] [Related]  

  • 59. [Application of IHW2 purged bone marrow to autologous bone marrow transplantation in the treatment of acute myeloid leukemia].
    Jiang R; Han M; Zhao Y
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):312-4. PubMed ID: 11243113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging.
    Janssen WE; Lee C; Gross S; Gee AP
    Exp Hematol; 1989 Mar; 17(3):252-7. PubMed ID: 2917623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.